Envestnet Asset Management’s Antares Pharma, Inc. ATRS Stock Holding History

Envestnet Asset Management’s Portfolio ATRS Stock Details ATRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-19,231	Closed	-$79K	–	4134
2022 Q1	$79K	Sell	19,231 -2,579	-12%	-$9.36K	﹤0.01%	3829
2021 Q4	$78K	Buy	21,810 +5,682	+35%	+$19.9K	﹤0.01%	3781
2021 Q3	$59K	Buy	16,128 +3,761	+30%	+$15.2K	﹤0.01%	3626
2021 Q2	$54K	Buy	+12,367	New	+$50.4K	﹤0.01%	3599
2020 Q2	–	Sell	-58,136	Closed	-$137K	–	3207
2020 Q1	$137K	Sell	58,136 -4,031	-6%	-$13.7K	﹤0.01%	2802
2019 Q4	$292K	Buy	62,167 +9,689	+18%	+$39.6K	﹤0.01%	2746
2019 Q3	$176K	Buy	52,478 +4,780	+10%	+$15.7K	﹤0.01%	2889
2019 Q2	$157K	Buy	47,698 +1,765	+4%	+$5.11K	﹤0.01%	2918
2019 Q1	$139K	Buy	+45,933	New	+$149K	﹤0.01%	2872

Other funds holding ATRS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Envestnet Asset Management's ATRS Position: Q2 2022 in Review

Envestnet Asset Management sold out of Antares Pharma, Inc. (ATRS) in Q2 2022, closing a stake of 19,231 shares — an estimated $79K sold.

Envestnet Asset Management first reported a position in ATRS in Q1 2019 and held it in 9 quarters. The position peaked at $292K in Q4 2019. 1 fund tracked by Wall St. Rank holds ATRS as of Q2 2022.

Envestnet Asset Management reported no remaining Antares Pharma, Inc. position as of Q2 2022 after selling out during the quarter.
Envestnet Asset Management sold 19,231 Antares Pharma, Inc. shares in Q2 2022, an estimated $79K.
Envestnet Asset Management first reported a position in Antares Pharma, Inc. in Q1 2019 and held it in 9 quarters.
Envestnet Asset Management's Antares Pharma, Inc. position peaked at $292K in Q4 2019.
1 fund tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2022.

Based on Envestnet Asset Management's 13F filing for Q2 2022, filed 3 Aug 2022.